RK
Ravindranath Kancherla
About Ravindranath Kancherla
Data last updated:
Ravindranath Kancherla is a Director at Laurus Labs Limited (since 2017), Nominee Director at Immunoadoptive Cell Therapy Private Limited (since 2021) and Managing Director at Global Hospitals Private Limited (since 2004), and holds 11 more current directorships. The companies operate in Pharma, Healthcare and Information Technology. The 7 current companies with reported revenue have a combined latest revenue of ₹6,981 Cr; the largest is Laurus Labs Limited at ₹6,868 Cr (FY 2026). Earlier, Ravindranath Kancherla was a Director at Penna Cement Industries Limited (2018–2024) and Director at Global Sunrise Medi Services Private Limited (2007–2023) and 12 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Laurus Labs Limited L24239AP2005PLC047518 | Director | 18 May 2017 | 2005 | ₹6,868 Cr (FY 2026) | Active |
 Immunoadoptive Cell Therapy Private Limited U74999MH2018PTC315497 | Nominee Director | 09 Dec 2021 | 2018 | ₹77.75 Cr (FY 2026) | Active |
 Global Hospitals Private Limited U85110TG1996PTC025213 | Managing Director | 30 Jan 2004 | 1996 | ₹21.33 Cr (FY 2025) | Active |
| Cognitivebotics Technologies Private Limited U72200TG2018PTC126851 | Additional Director | 05 Sep 2021 | 2018 | ₹12.99 Cr (FY 2024) | Active |
| Ravindranath Medical Foundation U85110TG1997NPL027669 | Director | 24 Aug 2019 | 1997 | ₹85.3 Lakh (FY 2025) | Active |
| Global University Foundation U80900TG2019NPL135587 | Director | 19 Sep 2019 | 2019 | ₹43.1 Lakh (FY 2025) | Active |
| Global Hospital (North) Limited U55101DL2005PLC135739 | Director | 03 May 2005 | 2005 | ₹15,000 (FY 2023) | Dormant Under Section 455 |
| Healthspan X Private Limited U86100TS2026PTC217760 | Director | 17 Jun 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Penna Cement Industries Limited U26942GJ1991PLC168781 | Director | 14 Jun 2018 | 1991 | ₹2,015 Cr (FY 2023) | Active |
| Global Sunrise Medi Services Private Limited U85195WB2007PTC114933 | Director | 02 Apr 2007 | 2007 | ₹48,000 (FY 2025) | Active |
 Gleneagles Healthcare India Private Limited U85110TN1998PTC093106 | Director | 01 Jan 1999 | 1998 | ₹1,065 Cr (FY 2025) | Active |
 Gleneagles Clinical Research Services (India) Private Limited U85110TG2006PTC050946 | Director | 23 Aug 2006 | 2006 | ₹2.58 Cr (FY 2025) | Active |
 Centre For Digestive And Kidney Diseases (India) Private Limited U85110MH2004PTC146014 | Director | 02 Jan 2005 | 2004 | ₹294 Cr (FY 2023) | Active |
| High Speed Transmission Solutions (India) Private Limited U32309TG2017PTC120678 | Director | 17 Nov 2017 | 2017 | Strike Off | |
 Rge Constructions And Development Private Limited U70101TN2007PLC064100 | Director | 25 Jun 2007 | 2007 | ₹2.01 Cr (FY 2025) | Active |
| Nexgen Futurus Private Limited U74999TG2017PTC120194 | Director | 24 Oct 2017 | 2017 | ₹77.3 Lakh (FY 2024) | Active |
| Hygieia Global Health Services Private Limited U74900TG2014PTC096462 | Director | 19 Nov 2014 | 2014 | ₹18.19 Cr (FY 2022) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravindranath Kancherla
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravindranath Kancherla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravindranath Kancherla
Ravindranath Kancherla currently holds 14 directorships: Laurus Labs Limited (Director, since 18 May 2017, revenue ₹6,868 Cr (FY 2026)); Immunoadoptive Cell Therapy Private Limited (Nominee Director, since 09 Dec 2021, revenue ₹77.75 Cr (FY 2026)); Global Hospitals Private Limited (Managing Director, since 30 Jan 2004, revenue ₹21.33 Cr (FY 2025)); Cognitivebotics Technologies Private Limited (Additional Director, since 05 Sep 2021, revenue ₹12.99 Cr (FY 2024)); Ravindranath Medical Foundation (Director, since 24 Aug 2019, revenue ₹85.3 Lakh (FY 2025)); and 9 more.
Ravindranath Kancherla was first appointed on 07 Aug 1998 as Director at Rainbow Children's Medicare Limited. The most recent appointment on record is 17 Jun 2026 at Healthspan X Private Limited.
The 7 current companies of Ravindranath Kancherla that report revenue have a combined latest revenue of ₹6,981 Cr: Laurus Labs Limited ₹6,868 Cr (FY 2026); Immunoadoptive Cell Therapy Private Limited ₹77.75 Cr (FY 2026); Global Hospitals Private Limited ₹21.33 Cr (FY 2025); Cognitivebotics Technologies Private Limited ₹12.99 Cr (FY 2024); Ravindranath Medical Foundation ₹85.3 Lakh (FY 2025); and 2 more.
Ravindranath Kancherla held 14 earlier board appointments: Penna Cement Industries Limited (Director, 14 Jun 2018 to 16 Aug 2024); Global Sunrise Medi Services Private Limited (Director, 02 Apr 2007 to 04 Dec 2023); Gleneagles Healthcare India Private Limited (Director, 01 Jan 1999 to 25 Sep 2023); Gleneagles Clinical Research Services (India) Private Limited (Director, 23 Aug 2006 to 25 Sep 2023); Centre For Digestive And Kidney Diseases (India) Private Limited (Director, 02 Jan 2005 to 25 Sep 2023); and 9 more.
The current boards of Ravindranath Kancherla's companies include Krishna Chaitanya Chava (Laurus Labs Limited), Ramesh Subrahmanian (Laurus Labs Limited), Satyanarayana Chava (Laurus Labs Limited), Satyanarayana Chava (Laurus Labs Limited), Sekar Karnam (Laurus Labs Limited), Shekhar Chintamani Mande (Laurus Labs Limited), among others.